Clinical Data

long shot miss basketball hoop fail shoot
Biotech

Tvardi's STAT3 inhibitor flunks IPF trial amid high dropout rate

The biotech reported high dropout rates and placebolike efficacy in a phase 2 trial of its idiopathic pulmonary fibrosis prospect.
Nick Paul Taylor Oct 13, 2025 9:25am
green light go go ahead advance yes streetlight

Moderna posts melanoma data behind decision to say 'I do' to IDO

Oct 13, 2025 5:15am
hearing audio waves

Regeneron shares updated data on hearing loss gene therapy

Oct 12, 2025 10:18am
An arrow incrementally going up stairs before pointing straight up Blue background

AstraZeneca's $1.3B bet yields 2nd phase 3 blood pressure win

Oct 7, 2025 4:01am
Close-up of human eye

Opus sets sights on FDA talks after posting gene therapy data

Sep 30, 2025 9:15am
Stock decreasing graphic

Applied Tx's stock drops on non-update for rare disease asset

Sep 29, 2025 10:57am